Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Michio Fujimaki"'
Autor:
Michio Fujimaki, Asashi Tanaka, Eizo Kakishita, Katsuyuki Fukutake, Hidenaga Hama, Midori Shima, Yasuharu Nishida, Akira Shirahata, Juzo Matsuda, Hiromu Fukui
Publikováno v:
Japanese Journal of Thrombosis and Hemostasis. 4:179-188
Phase I and II clinical studies were performed to evaluate the safety, efficacy and pharmacokinetics of recombinant factor VIII (BL-160) in hemophilia A patients. Three and seven patients were enrolled in the phase I and phase II study respectively.
Autor:
Hidehiko Saito, Junichi Mimaya, Morimi Shimada, Akira Shibata, Akira Yoshioka, Hoyu Takahashi, Hidenaga Hama, Midori Shima, Hideji Hanabusa, Seiji Kinoshita, Juzo Matsuda, Masaaki Ishikawa, Giichi Tsujino, Katsuyuki Fukutake, Shigeru Ohta, Minoru Inagaki, Takayoshi Toyota, Kojiro Honda, Takeo Takeda, Kanji Ogata, Asashi Tanaka, Junki Takamatsu, Michio Fujimaki, Eizo Kakishita, Yoshio Hatae, Yasuharu Nishida, Akira Shirahata
Publikováno v:
Japanese Journal of Thrombosis and Hemostasis. 4:430-440
Publikováno v:
Japanese Journal of Thrombosis and Hemostasis. 3:178-184
Autor:
Akira Shibata, Minoru Inagaki, Yasuyuki Endo, Joichi Nomura, Hoyu Takahashi, Eizo Kakishita, Kunio Kishida, Kazuo Mori, Yutaka Yoshida, Katsumi Deguchi, Akira Shirahata, Hisao Ikari, Noboru Takata, Norio Kobayashi, Noriyuki Kawasaki, Keiichiro Yoshioka, Shigeru Shirakawa, Michio Fujimaki, Kaneo Yamada, Kojiro Honda, Akira Yoshioka, Nobuo Sakuragawa, Juzo Matsuda, Junichi Mimaya, Hiromu Fukui, Tomoo Kainuma
Publikováno v:
Japanese Journal of Thrombosis and Hemostasis. 2:302-310
In order to reduce risk factors in the treatment of hemophilia B with prothrombin complex concentrates, a new coagulation factor IX concentrate (GA-1013) was developed by Green Cross Corporation, Osaka, Japan. This product is prepared by immunoaffini
Autor:
Kazuko Kuroso, Michio Fujimaki
Publikováno v:
Japanese Journal of Thrombosis and Hemostasis. 2:82-89
Publikováno v:
Japanese Journal of Thrombosis and Hemostasis. 1:219-224
Publikováno v:
Thrombosis and haemostasis. 68(4)
SummaryPlasma thrombomodulin (TM) has attracted considerable attention as a marker of endothelial cell membrane injury. We examined fluctuations in plasma TM levels in patients receiving therapy for the disseminated intravascular coagulation syndrome
Autor:
Hisashi Yorifuji, Katsuhiro Fukutake, Hiroshi Nagasawa, Michio Fujimaki, Toshihito Katsumura, Hisao Iwane, Shojiro Ikematsu, Morio Arai, Toshihiko Ishii
Publikováno v:
Thrombosis research. 57(3)
Publikováno v:
Blood & Vessel. 14:501-504
Publikováno v:
Blood & Vessel. 10:232-236
Defibrinogenation therapy is expected to be a new type of anticoagulant therapy without serious bleeding complications. However, it appears to be dangerous to perform surgical procedure in the defibrinogenated state.In order to investigate the causes